Literature DB >> 22532289

Some chronic rhinosinusitis patients have elevated populations of fungi in their sinuses.

Andrew H Murr1, Andrew N Goldberg, Steven D Pletcher, Kelsey Dillehay, Larry J Wymer, Stephen J Vesper.   

Abstract

OBJECTIVES/HYPOTHESIS: To measure the populations of 36 fungi in the homes and sinuses of chronic rhinosinusitis (CRS) and non-CRS patients. STUDY
DESIGN: Single-blind cross-sectional study.
METHODS: Populations of 36 fungi were measured in sinus samples and in the home vacuum cleaner dust of CRS (n = 73) and non-CRS patients (n = 16) using quantitative polymerase chain reaction. Etest strips containing amphotericin B, anidulafungin, caspofungin, fluconazole, and voriconazole were used to test the susceptibility of seven potentially relevant fungi.
RESULTS: Seven fungi (Alternaria alternata, Cladosporium cladosporioides types 1 and 2, Cladosporium herbarum, Penicillium brevicompactum, Penicillium crustosum, and Penicillium chrysogenum type 2) were discovered at very high concentrations in some CRS patients. In vitro antifungal susceptibility testing of these seven fungi demonstrated species specific sensitivities. Four CRS patients with marked elevations of fungal populations in their sinus samples underwent endoscopic sinus surgery. After surgical treatment, the fungal populations were reduced by several orders of magnitude.
CONCLUSIONS: Seven fungi were found in very high concentrations in the sinuses of some CRS patients. Not one of the five common antifungal agents could control all seven of these fungi based on in vitro tests.
Copyright © 2012 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22532289      PMCID: PMC7165593          DOI: 10.1002/lary.23295

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  22 in total

1.  Quantitative PCR analysis of selected Aspergillus, Penicillium and Paecilomyces species.

Authors:  Richard A Haugland; Manju Varma; Larry J Wymer; Stephen J Vesper
Journal:  Syst Appl Microbiol       Date:  2004-03       Impact factor: 4.022

2.  Activity of nasal amphotericin B irrigation against fungal organisms in vitro.

Authors:  Mobeen A Shirazi; James A Stankiewicz; Pat Kammeyer
Journal:  Am J Rhinol       Date:  2007 Mar-Apr

Review 3.  Nasal amphotericin irrigation in chronic rhinosinusitis.

Authors:  James A Stankiewicz; Brandon K Musgrave; Joseph M Scianna
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2008-02       Impact factor: 2.064

4.  Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis.

Authors:  Fenna A Ebbens; Glenis K Scadding; Lydia Badia; Peter W Hellings; Mark Jorissen; Joaquim Mullol; Alda Cardesin; Claus Bachert; Thibaut P J van Zele; Marcel G W Dijkgraaf; Valerie Lund; Wytske J Fokkens
Journal:  J Allergy Clin Immunol       Date:  2006-11       Impact factor: 10.793

5.  Bacterial cultures of the middle meatus and bronchoalveolar lavage in chronic rhinosinusitis.

Authors:  Ahmed Ragab; Peter Clement; Walter Vincken
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2006-11-24       Impact factor: 1.538

Review 6.  Rhinosinusitis: establishing definitions for clinical research and patient care.

Authors:  Eli O Meltzer; Daniel L Hamilos; James A Hadley; Donald C Lanza; Bradley F Marple; Richard A Nicklas; Claus Bachert; James Baraniuk; Fuad M Baroody; Michael S Benninger; Itzhak Brook; Badrul A Chowdhury; Howard M Druce; Stephen Durham; Berrylin Ferguson; Jack M Gwaltney; Michael Kaliner; David W Kennedy; Valerie Lund; Robert Naclerio; Ruby Pawankar; Jay F Piccirillo; Patricia Rohane; Ronald Simon; Raymond G Slavin; Alkis Togias; Ellen R Wald; S James Zinreich
Journal:  J Allergy Clin Immunol       Date:  2004-12       Impact factor: 10.793

Review 7.  Antifungal therapy for chronic rhinosinusitis: the controversy persists.

Authors:  Matthew A Rank; Cheryl R Adolphson; Hirohito Kita
Journal:  Curr Opin Allergy Clin Immunol       Date:  2009-02

8.  Antifungal treatment and chronic rhinosinusitis.

Authors:  Devyani Lal; James A Stankiewicz
Journal:  Curr Allergy Asthma Rep       Date:  2009-05       Impact factor: 4.806

9.  Current estimates from the National Health Interview Survey, 1995.

Authors:  V Benson; M A Marano
Journal:  Vital Health Stat 10       Date:  1998-10

10.  Geographic distribution of Environmental Relative Moldiness Index molds in USA homes.

Authors:  Stephen Vesper; Jennie Wakefield; Peter Ashley; David Cox; Gary Dewalt; Warren Friedman
Journal:  J Environ Public Health       Date:  2011-06-07
View more
  6 in total

Review 1.  Microbiome of the paranasal sinuses: Update and literature review.

Authors:  Jivianne T Lee; Daniel N Frank; Vijay Ramakrishnan
Journal:  Am J Rhinol Allergy       Date:  2016 Jan-Feb       Impact factor: 2.467

Review 2.  Role of fungi in the pathophysiology of chronic rhinosinusitis: an update.

Authors:  Kathleen T Montone
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

3.  Increased risk of open-angle glaucoma following chronic rhinosinusitis: a population-based matched-cohort study.

Authors:  S-D Chung; C-C Lin; J-D Ho; J Ting; H-C Lin; C-C Hu
Journal:  Eye (Lond)       Date:  2013-11-22       Impact factor: 3.775

Review 4.  Pathology of Fungal Rhinosinusitis: A Review.

Authors:  Kathleen T Montone
Journal:  Head Neck Pathol       Date:  2016-02-01

Review 5.  Association Between Microbiota and Nasal Mucosal Diseases in terms of Immunity.

Authors:  Junhu Tai; Mun Soo Han; Jiwon Kwak; Tae Hoon Kim
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

Review 6.  Chronic illness associated with mold and mycotoxins: is naso-sinus fungal biofilm the culprit?

Authors:  Joseph H Brewer; Jack D Thrasher; Dennis Hooper
Journal:  Toxins (Basel)       Date:  2013-12-24       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.